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Abstract
Background: Anal metastases from lung cancer are infrequent, and there are only 10 published cases. Life
expectancy is no longer than 1 year after diagnosis because of the typically advanced stage of disease. Treatment,
which is typically inefficient, is administered with the intent to cure or avoid local complications.
Case presentation: We report a case of a patient with non-small cell lung cancer presenting with perianal
metastasis mimicking an abscess.
Conclusions: Because perianal masses may be misdiagnosed, patients with lung and other cancers should be
evaluated for metastatic disease.
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Background
It is very rare for metastases from lung cancers to reside
in the anal and/or perianal regions or to associate with
multiple metastases in other organs [1]. Accordingly,
there are few published reports of this phenomenon. Life
expectancy is very short in such cases because this
localization represents the dissemination of an aggressive
cancer [2]. We describe a patient with non-small cell
lung cancer (NSCLC) presenting with perianal meta-
static disease mimicking an abscess.
Case presentation
A 75-year-old man presented on July 2014 with weight
loss, loss of appetite, and fatigue. He was a heavy smoker
who smoked one pack of cigarettes daily for 40 years. A
chest X-ray revealed a homogenous opacity in the left-
apical region. Computed tomography (CT) of the chest
detected a mass in the left-apical segment (5.3 cm ×
6 cm × 6.5 cm) with tiny focal calcifications within the
mass, erosion of the left posterior region of the second
rib, and multiple mediastinal lymph nodes <1 cm. Histo-
pathological analysis led to the diagnosis of NSCLC
consistent with adenocarcinoma.
A CT scan of the abdomen and pelvis did not detect
metastasis, and magnetic resonance imaging did not de-
tect intracranial metastases. Iron deficiency anemia
(hemoglobin = 10.2 g/dL) was present. Positron emission
tomography (PET) detected intense hypermetabolism in
the known left-apical Pancoast tumor, which appeared
to invade the thoracic intervertebral foramina with me-
diastinal and the left axillary lymph node, a suspicious
C5 vertebral body metastasis, and intense uptake of
tracer in the gastric wall, likely representing a malig-
nancy. Magnetic resonance imaging of the spine de-
tected a left-lung apical tumor with encroachment of the
left supraclavicular region as well as extension into the left
intervertebral DV1 and DV2 foramina. The tumor dis-
placed, compressed, and invaded the adjacent trunks and
distal roots of the brachial plexus with edema surrounding
the root of the left neck, the ipsilateral brachial plexus,
and the left shoulder with alteration of signal intensities of
peri-shoulder muscular anatomy. Upper gastrointestinal
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endoscopy revealed status post Billroth 2 surgery with ero-
sive gastritis without malignancy.
Palliative radiotherapy of the primary tumor was ad-
ministered along with pemetrexed and carboplatin, and
zoledronic acid was continued. In October 2014, the
patient presented with pain and tenderness in the left
lower chest wall. Ultrasonography revealed a slightly
heterogeneous liver mass with small hyperechoic foci
(<1 cm) within the right hepatic lobe and a heteroge-
neous hypoechoic lesion (4.6 × 3.1 cm) in the left ad-
renal. A CT scan of the chest showed a soft-tissue dense
ovoid mass (approximately 3 cm × 4.5 cm along the right
lower chest wall anterior and opposite the anterior ends
of the seventh and eighth ribs). A PET scan revealed
high tracer uptake into the newly developed bilateral ad-
renal metastasis and right chest wall lesion. Anal tracer
uptake suggested metastasis, and we discontinued test-
ing because the patient was asymptomatic (Fig. 1).
The patient was referred for surgery in February 2015
with a complaint of severe perianal pain and involuntary
defecation. A painful, fungating, and red to brown ulcer-
ating mass (approximately 3 cm × 4 cm) was present
near the anal orifice, which was covered by friable tissue
with traces of stool (Fig. 2). Histopathology detected a
metastatic, poorly differentiated carcinoma with histomor-
phology and immunohistochemical findings (CKAE1/AE3
+, vimentin+) identical to those of the lung tumor (Fig. 3).
The patient became severely cachectic and delirious and
was short of breath. He died in March 2015 after receiving
palliative care.
Discussion
Lung cancer is the most frequent malignancy with a high
mortality rate [3], and patients with NSCLC account for
80–85 %. Adenocarcinomas represent approximately
40 % of NSCLC [4]. When first diagnosed, approxi-
mately 40 % of patients with NSCLC harbor distant me-
tastases, and the recurrence rate is high in patients with
early disease [4]. Most metastatic lung cancers directly
invade other organs and spread through the blood or
lymph as well. The brain, bones, adrenal glands, and
bone marrow are common metastatic sites of lung can-
cers compared with the gastrointestinal tract [2].
Fig. 1 Maximum intensity projection (MIP) image of 18F-fluorodeoxyglucose-staging PET/CT showing hypermetabolic left-lung primary and mediastinal/
left axillary lymph node involvement (1a). Transaxial superimposed PET/CT images showing no focal pathological uptake at the anus (1b). After four
cycles of chemotherapy, the MIP image revealed new involvement of the adrenals, multiple bone metastases, and perianal uptake. Partial metabolic
response in the left primary lung tumor (2a). Transaxial superimposed PET/CT images showing intense focal uptake at the left aspect of the anus (2b)
Al-Tarakji et al. World Journal of Surgical Oncology  (2016) 14:157 Page 2 of 5
Autopsy findings indicate that the rate of gastrointes-
tinal metastases from primary lung carcinomas ranges
between 4.7 and 14 % [5]. The esophagus is commonly
invaded by direct extension, whereas the stomach is in-
vaded through the lymphatics. One study detected meta-
static cells in the small and large bowels [5]. Anal cancers
represent 1–2 % of gastrointestinal cancers in the USA;
metastatic lesions are less frequent (http://www.fascrs.org/
patients/conditions/analcancer/), and metastatic colon
cancer and exfoliation cause most cases [6]. In contrast,
metastasis to the intestine from the stomach to the anus is
likely caused by retrograde spread through the lymphatics
that connect the lung through the mediastine to the intes-
tines [4]. Suspicious hematogenous spread, consequent to
cardiopulmonary bypass circuit used to remove a lung
tumor protruding into the atrium, has been reported [7].
However, we were unable to determine the route of me-
tastasis in our patient.
There are 11 reports of perianal and anal metastases
from primary lung cancers, including the present study
(Table 1) [1, 6–14]. The 10 patients with NSCLC in-
cluded five with adenocarcinomas. Anal metastases were
Fig. 2 Anal metastases
Fig. 3 Histopathological analysis of the anal mass revealed poorly differentiated carcinoma comprising large round cells with abundant
cytoplasm and large nuclei with one to two prominent nucleoli
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Table 1 Major characteristics of patients reported in the literature
Year Journal First author Age Sex Primary Metastases Presentation Syn or Met Sin or Mul Treatment Survival
1968 Dis Colon Rectum [3] Ger R 49 M Squamous cell
carcinoma (NSCLC)




1975 Dis Colon Rectum [4] Kanhouwa S 45 M Anaplastic large-cell
carcinoma (NSCLC)
Mediastinum; anus Anal ulcer Met Mul CCNU and hydroxyurea;
radiotherapy
10 months
1988 Gan No Rinsho [5] Uenura Y 78 M Mucoepidermoid
carcinoma (NSCLC)
Multiple (nr); anus Perianal mass Syn Mul Radiotherapy <1 year
1994 Surg Today [6] Kawahara K 75 M Squamous cell
carcinoma (NSCLC)
Atrium; anus Anal polyp Met Mul Transanal polypectomy nr
2006 Gastroenterolo
Clin Biol [7]




Anal abscess Met Mul Incision and drainage 1 month
2007 Southern Medical
Journal [8]
Tek I 50 M Adenocarcinoma
(NSCLC)
Anus Anal abscess Met Sin Chemotherapy; drainage
of abscess
nr
2010 J Buon [1] Okutur K 64 M Squamous cell
carcinoma (NSCLC)
Pleura; anus Anal polyp Met Mul Excision of the polyp;
radiotherapy
nr
2013 Clin Resec Hepat
Gastroent[10]




Perianal ulceration Syn Mul Chemotherapy nr
2014 Inter Medic [11] Imai H 36 F Adenocarcinoma
(NSCLC)
Subcutaneous; anus Perianal mass Met Mul Resection of perianal
mass
nr
2015 Int J Colorectal Dis [12] Guerra F 75 F Small cell lung cancer
(SCLC)
Anus Perianal abscess Met Sin Chemotherapy nr
2015 Present study Al Tarakji M 75 M Adenocarcinoma
(NSCLC)
Bone; anus Perianal abscess Met Mul Supportive care 1 month













metachronous in 8/11 patients; other metastatic sites
were present, and an abscess was the most prevalent
finding. Every abscess or fistula in at-risk patients, such
as smokers, has to be considered as a potential meta-
static tumor from the lung. Establishing a diagnosis must
account for adenocarcinomas arising from a fistula associ-
ated with Crohn’s disease [15], an anal gland adenocarcin-
oma [16], or rare metastases from breast [17], pancreatic
[18], or renal cancer [19]. Patients should be administered
single or combined chemotherapy and radiotherapy, be-
cause surgery with curative intent is ineffective and should
only address complications. A surgical biopsy can be per-
formed only with diagnosis intent. The palliative surgery
can be admitted in case of hemorrhage, external mass
with high discomfort for the patient, stenosis, or obstruc-
tion of the anal canal [14]. Nevertheless, survival does not
exceed 1 year from diagnosis. Together, the present and
published cases indicate that perianal masses may be mis-
diagnosed and patients with NSCLC or other cancers
should be evaluated for metastatic disease.
Conclusions
Because perianal masses may be misdiagnosed, patients
with lung and other cancers should be evaluated for
metastatic disease.
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